Feature | Published:

Drug innovation—what's slowing it down?

The research and introduction of new drugs has been slowing down in the UK and the US. At the same time, government regulations on the safety of new drugs have increased. But Fred Steward and George Wibberley argue that there is not a simple relationship between these two trends

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.